Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression.

about

The Role of TAM Family Receptors in Immune Cell Function: Implications for Cancer Therapy AXL is a marker for epithelial-mesenchymal transition in esophageal squamous cell carcinoma.

P2860

Q27928010-302C1D67-9FEB-4AC6-BA55-30E6D8A4DA33 Q50053695-BF7AEB91-2E70-4F46-87AC-CCA5307DFD98

P2860

Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression.

Item

http://www.wikidata.org/entity/Q35995940

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Clinical, Pathological, and Mo ...... arcinomas with AXL Expression.

@ast

Clinical, Pathological, and Mo ...... arcinomas with AXL Expression.

@en

type

Item

label

Clinical, Pathological, and Mo ...... arcinomas with AXL Expression.

@ast

Clinical, Pathological, and Mo ...... arcinomas with AXL Expression.

@en

prefLabel

Clinical, Pathological, and Mo ...... arcinomas with AXL Expression.

@ast

Clinical, Pathological, and Mo ...... arcinomas with AXL Expression.

@en

P1476

Clinical, Pathological, and Mo ...... arcinomas with AXL Expression.

@en

P2093

Hiroshi Mizuuchi

http://www.w3.org/2001/XMLSchema#string

Kazuko Sakai

http://www.w3.org/2001/XMLSchema#string

Kazuto Nishio

http://www.w3.org/2001/XMLSchema#string

Kenji Tomizawa

http://www.w3.org/2001/XMLSchema#string

Shigeki Shimizu

http://www.w3.org/2001/XMLSchema#string

Toshiki Takemoto

http://www.w3.org/2001/XMLSchema#string

P2860

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival.

Large-scale East-Asian eQTL mapping reveals novel candidate genes for LD mapping and the genomic landscape of transcriptional effects of sequence variants

Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a meta-analysis

AXL mediates resistance to cetuximab therapy

Chemoradiation provides a physiological selective pressure that increases the expansion of aberrant TP53 tumor variants in residual rectal cancerous regions.

Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma

Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancer

P304

e0154186

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0154186

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tetsuya Mitsudomi

Kenichi Suda

Katsuaki Sato

P577

2016-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27100677

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

4839706

http://www.w3.org/2001/XMLSchema#string

Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression.

about

P2860

P2860

Clinical, Pathological, and Molecular Features of Lung Adenocarcinomas with AXL Expression.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932